Clinical Trials Browser

Phase 2 × UNKNOWN × Lymphoma, Large B-Cell, Diffuse × Clear all

NCT04425824 2020-06-16

Toripalimab Combine With Rituximab for Treatment of Relapsed Refractory CD20 Positive Diffuse Large B-cell Lymphoma

Phase 2 Unknown

Lymphoma, Large B-Cell, Diffuse

NCT04023916 2019-12-11

Sintilimab Plus R-CHOP as the First-line Treatment in Patients With Diffuse Large B-Cell Lymphoma.

Phase 2 Unknown

Lymphoma, Large B-Cell, Diffuse